H. Pylori Infection
Conditions
Brief summary
This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .
Interventions
DRUGEfficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection
we assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient.
DRUGEfficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection
we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.
DRUGEfficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection
we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.
Sponsors
Sohag University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age: \>18 years old. * H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test).
Exclusion criteria
* Prior H. pylori treatment: Previous treatment for H. pylori infection. * Allergies: Known allergies to study medications or components. * Patients cannot finish treatment course. * Patient missed follow up. * Patients refusing or neglecting test of cure for H. pylori.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| efficacy medical treatment for eradication of Helicobacter Pylori infection in naive patient. | 4 weeks after successful medical treatment | stool antigen for H. Pylori |
Countries
Egypt
Contacts
Primary ContactAndrew K Wadea, Resident
Backup ContactHamdy S Mohammed, Professor
Outcome results
None listed